Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lane

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Research Square|September 16, 2024
ATM phosphorylation of CD98HC increases antiporter membrane localization and prevents chronic toxic glutamate accumulation in Ataxia telangiectasiaAlexander Bishop, July Carolina Romero, Sonal Tonapi, et al.
Human Mutation|July 22, 2010
Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasiaClaus E Ott, Gundula Leschik, Fabienne Trotier, et al.
Lancet (London, England)|May 18, 2025
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studiesBeryl B Cummings, Mark P Joing, Page R Bouchard, et al.
International Forum of Allergy & Rhinology|February 19, 2016
International Consensus Statement on Allergy and Rhinology: RhinosinusitisRichard R Orlandi, Todd T Kingdom, Peter H Hwang, et al.
International Forum of Allergy & Rhinology|November 25, 2020
International consensus statement on allergy and rhinology: rhinosinusitis 2021Richard R Orlandi, Todd T Kingdom, Timothy L Smith, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Research Square|September 16, 2024
ATM phosphorylation of CD98HC increases antiporter membrane localization and prevents chronic toxic glutamate accumulation in Ataxia telangiectasiaAlexander Bishop, July Carolina Romero, Sonal Tonapi, et al.
Human Mutation|July 22, 2010
Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasiaClaus E Ott, Gundula Leschik, Fabienne Trotier, et al.
Lancet (London, England)|May 18, 2025
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studiesBeryl B Cummings, Mark P Joing, Page R Bouchard, et al.
International Forum of Allergy & Rhinology|February 19, 2016
International Consensus Statement on Allergy and Rhinology: RhinosinusitisRichard R Orlandi, Todd T Kingdom, Peter H Hwang, et al.
International Forum of Allergy & Rhinology|November 25, 2020
International consensus statement on allergy and rhinology: rhinosinusitis 2021Richard R Orlandi, Todd T Kingdom, Timothy L Smith, et al.
Pageof 5